日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular landscape of Berberine's therapeutic potential in gastrointestinal disorders

小檗碱在胃肠道疾病治疗中的分子机制及其潜在疗效

Wu, Yang; Yinghui, L I; Heng, Liao; Shangbin, Xiong

Prevalence and Factors Associated With Patient-Clinician Discordance Among Patients With Rheumatoid Arthritis Initiating Advanced Therapy

类风湿性关节炎患者开始接受高级治疗时,患者与临床医生意见不一致的发生率及相关因素

Curtis, Jeffrey R; McLean, Robert R; Lee, I-Heng; Mackey, Rachel H; Moore, Page C; Haubrich, Richard; Greenberg, Jeffrey D; Wu, Alicea

Risk Factors of Ixekizumab-Induced Injection Site Reactions in Patients with Psoriatic Diseases: Report from a Single Medical Center

银屑病患者接受伊克珠单抗注射后发生注射部位反应的危险因素:来自单一医疗中心的报告

Chiu, I-Heng; Tsai, Tsen-Fang

Economic impact of applying the AASLD-IDSA simplified treatment algorithm on the real-world management of hepatitis C

应用AASLD-IDSA简化治疗方案对丙型肝炎实际治疗的经济影响

Majethia, Sunil; Lee, I-Heng; Chastek, Ben; Bunner, Scott; Wolf, John; Hsiao, Alice; Mozaffari, Essy

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

瑞德西韦治疗重症冠状病毒病 (COVID-19) 与接受标准治疗的队列研究

Olender, Susan A; Perez, Katherine K; Go, Alan S; Balani, Bindu; Price-Haywood, Eboni G; Shah, Nirav S; Wang, Su; Walunas, Theresa L; Swaminathan, Shobha; Slim, Jihad; Chin, BumSik; De Wit, Stéphane; Ali, Shamim M; Soriano Viladomiu, Alex; Robinson, Philip; Gottlieb, Robert L; Tsang, Tak Yin Owen; Lee, I-Heng; Hu, Hao; Haubrich, Richard H; Chokkalingam, Anand P; Lin, Lanjia; Zhong, Lijie; Bekele, B Nebiyou; Mera-Giler, Robertino; Phulpin, Chloé; Edgar, Holly; Gallant, Joel; Diaz-Cuervo, Helena; Smith, Lindsey E; Osinusi, Anu O; Brainard, Diana M; Bernardino, Jose I

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database

日本医疗数据视觉数据库中非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH) 患者的合并症、医疗保健成本和资源利用情况

Terai, Shuji; Buchanan-Hughes, Amy; Ng, Alvin; Lee, I-Heng; Hasegawa, Ken

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality

瑞德西韦与标准疗法治疗重症冠状病毒病2019感染:28天死亡率分析

Olender, Susan A; Walunas, Theresa L; Martinez, Esteban; Perez, Katherine K; Castagna, Antonella; Wang, Su; Kurbegov, Dax; Goyal, Parag; Ripamonti, Diego; Balani, Bindu; De Rosa, Francesco G; De Wit, Stéphane; Kim, Shin-Woo; Diaz, George; Bruno, Raffaele; Mullane, Kathleen M; Lye, David Chien; Gottlieb, Robert L; Haubrich, Richard H; Chokkalingam, Anand P; Wu, George; Diaz-Cuervo, Helena; Brainard, Diana M; Lee, I-Heng; Hu, Hao; Lin, Lanjia; Osinusi, Anu O; Bernardino, Jose I; Boffito, Marta

DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination

DUSP2调节细胞外囊泡VEGF-C的分泌和胰腺癌早期播散

Chu-An Wang, I-Heng Chang, Pei-Chi Hou, Yu-Jing Tai, Wan-Ning Li, Pei-Ling Hsu, Shang-Rung Wu, Wen-Tai Chiu, Chien-Feng Li, Yan-Shen Shan, Shaw-Jenq Tsai

Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review

日本非酒精性脂肪肝病和非酒精性脂肪性肝炎的流行病学:文献综述

Eguchi, Yuichiro; Wong, Gabriel; Lee, Emma I-Heng; Akhtar, Omar; Lopes, Ricardo; Sumida, Yoshio

Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

更正:纳武利尤单抗联合舒尼替尼或帕唑帕尼治疗晚期或转移性肾细胞癌的安全性和有效性:CheckMate 016 研究

Amin, Asim; Plimack, Elizabeth R; Ernstoff, Marc S; Lewis, Lionel D; Bauer, Todd M; McDermott, David F; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I; Heng, Daniel Y C; Knox, Jennifer; Voss, Martin H; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J